
| Foot Skin | £300m |
| Warts and Verrucae | £225m |
| Cold Sore | £450m |
| Fungal Nails | £200m |
| Total worldwide value | £1.2bn |
Basis IRI stats 2005 for UK multiplied by UK GDP as % of 2008 EU GDP (source EU stats) and by EU % of world OTC market 36% (source James Dudley MedOTCeurope 2007).